作者:
Emina E,Torlakovic [1]
;
Søren,Nielsen ;
Glenn,Francis ;
John,Garratt ;
Blake,Gilks ;
Jeffrey D,Goldsmith ;
Jason L,Hornick ;
Elizabeth,Hyjek ;
Merdol,Ibrahim ;
Keith,Miller ;
Eugen,Petcu ;
Paul E,Swanson ;
Xiaoge,Zhou ;
Clive R,Taylor ;
Mogens,Vyberg
作者单位:
*Department of Laboratory Hematology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON **Vancouver Costal Health ††Vancouver General Hospital/University of British Columbia, Vancouver, BC ##Department of Pathology, University of Calgary, Calgary, AB, Canada †Canadian Immunohistochemistry Quality Control (CIQC), Vancouver, BC, Canada ‡Institute of Pathology, Aalborg University Hospital, Denmark §Nordic Immunohistochemistry Quality Control (NordiQC), Aalborg, Denmark ∥Griffith University School of Medicine, Gold Coast Campus ¶Australian Institute for Bioengineering and Nano-Technology, University of Queensland, Qld, Australia #Convenor Immunohistochemistry, Anatomical Pathology Program, RCPA QAP Pty Ltd., Sydney, Australia ‡‡Beth Israel Deaconess Medical Center §§Brigham and Women's Hospital, Harvard medical School, Boston, MA ∥∥UK National External Quality Assessment Scheme (UK NEQAS), University College London, London, UK ¶¶University of Washington, Seattle, WA ***Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China †††Chinese Committee for Pathology-Immunohistochemistry Quality Control (CCP-IHCQC) ‡‡‡Keck School of Medicine, University of Southern California, Los Angeles, CA.
[1]
DOI
10.1097/PAI.0000000000000163
PMID
25474126
发布时间
2016-10-20